Page last updated: 2024-08-23

tobramycin and mannitol

tobramycin has been researched along with mannitol in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's1 (11.11)18.2507
2000's1 (11.11)29.6817
2010's6 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A1
Perkins, BA; Strausbaugh, LJ1
Dahl, RH; Ford, DM; Lamp, CA; Molitoris, BA1
Barraud, N; Buson, A; Jarolimek, W; Rice, SA1
Steinkamp, G1
Hebert, WP; Mastoridis, P; O'Toole, GA; Orazi, G; Price, KE; Ruoff, KL1
Cavallaro, G; Craparo, EF; Cusimano, MG; Giammona, G; Porsio, B; Schillaci, D; Spigolon, D1

Reviews

1 review(s) available for tobramycin and mannitol

ArticleYear
[Dry powder inhalers in cystic fibrosis].
    Pneumologie (Stuttgart, Germany), 2014, Volume: 68, Issue:6

    Topics: Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Diuretics, Osmotic; Drug Compounding; Dry Powder Inhalers; Humans; Mannitol; Powders; Pseudomonas Infections; Tobramycin

2014

Other Studies

8 other study(ies) available for tobramycin and mannitol

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:1

    Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics

2011
Effect of mannitol infusions into the internal carotid artery on entry of two antibiotics into the cerebrospinal fluid and brains of normal rabbits.
    Antimicrobial agents and chemotherapy, 1983, Volume: 24, Issue:3

    Topics: Animals; Brain; Carotid Artery, Internal; Drug Interactions; Infusions, Intra-Arterial; Mannitol; Rabbits; Time Factors; Tobramycin; Vancomycin

1983
Apically and basolaterally internalized aminoglycosides colocalize in LLC-PK1 lysosomes and alter cell function.
    The American journal of physiology, 1994, Volume: 266, Issue:1 Pt 1

    Topics: Aminoglycosides; Animals; Basement Membrane; Biological Transport; Cell Line; Cell Membrane; Ferritins; Gentamicins; Immunohistochemistry; Intracellular Membranes; Kidney Tubules, Proximal; Lysosomes; Mannitol; Tissue Distribution; Tobramycin

1994
Mannitol enhances antibiotic sensitivity of persister bacteria in Pseudomonas aeruginosa biofilms.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: Anti-Bacterial Agents; Biofilms; Cystic Fibrosis; Diuretics, Osmotic; Drug Resistance, Bacterial; Humans; Mannitol; Mutation; Pneumonia, Bacterial; Pseudomonas aeruginosa; Tobramycin

2013
Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation.
    PloS one, 2015, Volume: 10, Issue:10

    Topics: Biofilms; Cystic Fibrosis; Humans; Lung; Mannitol; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

2015
Polyanion-tobramycin nanocomplexes into functional microparticles for the treatment of Pseudomonas aeruginosa infections in cystic fibrosis.
    Nanomedicine (London, England), 2017, Volume: 12, Issue:1

    Topics: Anti-Bacterial Agents; Cell Line; Cystic Fibrosis; Drug Carriers; Drug Liberation; Epithelial Cells; Humans; Mannitol; Mucus; Nanocomposites; Polyelectrolytes; Polymers; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

2017